Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Summary

A multicenter, open-label expanded access program to provide access to tazemetostat to Epithelioid Sarcoma (ES) patients in serious need who are otherwise unable to participate in a clinical study or whom access is not available through marketed product in the US.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications